Article: article from journal or magazin.
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Traitements actuels du lymphome folliculaire [Current treatment of follicular lymphoma]
Revue Médicale Suisse
After diffuse large B-cell lymphoma, follicular lymphoma is the most frequent non-Hodgkin's lymphoma. It remains incurable, except for localized diseases. Advanced disease has to be treated only in the presence of clinical and/or biology aggressiveness. These patients should be treated by rituximab (Mab-Thera) associated to polychemotherapy comprising cyclophosphamide, vincristine and prednisone. After this therapy, the benefit of rituximab in maintenance has to be confirmed. Autologous stem cell transplantation is now reserved for young patients in first relapse. Allogenic stem cell transplantation is also an interesting option. The other therapeutic options comprise radio-immunotherapy with 90Y ibritumomab tiuxetan (Zevalin) and bortezomib (Velcade).
Antibodies, Monoclonal/administration & dosage, Antibodies, Monoclonal/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Boronic Acids/administration & dosage, Chemotherapy, Adjuvant, Cyclophosphamide/administration & dosage, Hematopoietic Stem Cell Transplantation, Humans, Lymphoma, Follicular/drug therapy, Lymphoma, Follicular/radiotherapy, Prednisone/administration & dosage, Prognosis, Pyrazines/administration & dosage, Radioimmunotherapy, Radiotherapy, Adjuvant, Risk Factors, Transplantation, Autologous, Transplantation, Homologous, Treatment Outcome, Vincristine/administration & dosage
Last modification date